Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Free Cash Flow (2020 - 2024)

Immuneering has reported Free Cash Flow over the past 5 years, most recently at -$14.5 million for Q4 2024.

  • Quarterly results put Free Cash Flow at -$14.5 million for Q4 2024, down 21.54% from a year ago — trailing twelve months through Dec 2024 was -$55.1 million (down 11.71% YoY), and the annual figure for FY2025 was -$45.5 million, up 17.42%.
  • Free Cash Flow for Q4 2024 was -$14.5 million at Immuneering, down from -$13.5 million in the prior quarter.
  • Over the last five years, Free Cash Flow for IMRX hit a ceiling of -$3.5 million in Q3 2020 and a floor of -$15.5 million in Q1 2024.
  • Median Free Cash Flow over the past 5 years was -$11.3 million (2022), compared with a mean of -$10.5 million.
  • Biggest five-year swings in Free Cash Flow: plummeted 159.08% in 2021 and later dropped 1.08% in 2023.
  • Immuneering's Free Cash Flow stood at -$5.5 million in 2020, then tumbled by 68.49% to -$9.3 million in 2021, then dropped by 27.73% to -$11.8 million in 2022, then fell by 1.08% to -$11.9 million in 2023, then fell by 21.54% to -$14.5 million in 2024.
  • The last three reported values for Free Cash Flow were -$14.5 million (Q4 2024), -$13.5 million (Q3 2024), and -$11.6 million (Q2 2024) per Business Quant data.